Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Michael E. Kelly MD, PhD

Michael E. Kelly MD, PhD

Associate Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Hematology/Oncology
Program: Oncology

Member of the Cancer Center


Research Experience

  • Leukemia
  • Vascular Neoplasms
  • Clinical Expertise

  • Hemangioma
  • Leukemia
  • Neoplasms, Vascular Tissue
  • Publications

  • Indications for transplantation in childhood acute leukemia and the impact of minimal residual disease on relapse: a review (Thakar MS, Talano J, Tower RL, Kelly ME, Burke MJ.) Clin. Pract.
  • A Pharmacokinetic Study of Intravenous Asparaginase Erwinia chrysanthemi Following Allergy to E coli-Derived Asparaginase in Children and Adolescents with Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (Vrooman LM, Kirov II, Dreyer ZE, Kelly ME, Hijiya N, et al.) Pediatric blood & cancer
  • The natural history of skin-limited Langerhans cell histiocytosis: a single-institution experience. (Ehrhardt MJ, Humphrey SR, Kelly ME, Chiu YE, Galbraith SS) J Pediatr Hematol Oncol 2014 Nov;36(8):613-6 PMID: 25171449
  • Early therapy-related myeloid sarcoma and deletion of 9q22.32 to q31.1. (Brickler MM, Basel DG, Gheorghe G, Margolis DM, Kelly ME, Ehrhardt MJ) Pediatr Blood Cancer 2014 Sep;61(9):1701-3 PMID: 24668947
  • Recognition and treatment of concurrent active and neurodegenerative langerhans cell histiocytosis: a case report. (Ehrhardt MJ, Karst J, Donohoue PA, Maheshwari M, McClain KL, Bingen K, Kelly ME) J Pediatr Hematol Oncol 2015 Jan;37(1):e37-40 PMID: 24322503
  • Recognition and treatment of concurrent active and neurodegenerative Langerhans cell histiocytosis: a case report. (Ehrhardt M, Karst J, Donohoue P, Maheshwari M, McClain K, et al.) Journal of pediatric hematology/oncology.
  • Treatment of relapsed precursor-B acute lymphoblastic leukemia with intensive chemotherapy: POG (Pediatric Oncology Group) study 9411 (SIMAL 9). (Kelly ME, Lu X, Devidas M, Camitta B, Abshire T, Bernstein ML, Billett A, Homans A, Sandler E, Buchanan G) J Pediatr Hematol Oncol 2013 Oct;35(7):509-13 PMID: 23887024 PMCID: PMC3957178
  • Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma. (Drolet BA, Trenor CC 3rd, Brandão LR, Chiu YE, Chun RH, Dasgupta R, Garzon MC, Hammill AM, Johnson CM, Tlougan B, Blei F, David M, Elluru R, Frieden IJ, Friedlander SF, Iacobas I, Jensen JN, King DM, Lee MT, Nelson S, Patel M, Pope E, Powell J, Seefeldt M, Siegel DH, Kelly M, Adams DM) J Pediatr 2013 Jul;163(1):285-91 PMID: 23796341
  • Wilms tumor presenting with Lambert-Eaton myasthenic syndrome. (Petersen CL, Hemker BG, Jacobson RD, Warwick AB, Jaradeh SS, Kelly ME) J Pediatr Hematol Oncol 2013 May;35(4):267-70 PMID: 23612377
  • Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon. (Chiu YE, Drolet BA, Blei F, Carcao M, Fangusaro J, Kelly ME, Krol A, Lofgren S, Mancini AJ, Metry DW, Recht M, Silverman RA, Tom WL, Pope E) Pediatr Blood Cancer 2012 Nov;59(5):934-8 PMID: 22648868 PMCID: PMC3528889
  • Endoscopic management of gastrointestinal bleeding from multifocal lymphangioendotheliomatosis with thrombocytopenia: limited efficacy and complications. (Noel RJ, Duffy KJ, Kelly ME, Tondravi N, North PE, Drolet BA) J Pediatr Gastroenterol Nutr 2012 Jun;54(6):822-4 PMID: 21788915
  • Microcystic adnexal carcinoma: the first reported congenital case. (Smart DR, Taintor AR, Kelly ME, Lyon VB, Segura A, Jensen JN, Drolet BA) Pediatr Dermatol 2011 Jan-Feb;28(1):35-8 PMID: 21276051
  • Kasabach-Merritt phenomenon. (Kelly M) Pediatr Clin North Am 2010 Oct;57(5):1085-9 PMID: 20888459
  • Immunosuppressive effects in infants treated with corticosteroids for infantile hemangiomas. (Kelly ME, Juern AM, Grossman WJ, Schauer DW, Drolet BA) Arch Dermatol 2010 Jul;146(7):767-74 PMID: 20479291
  • Expanding the phenotype of multifocal lymphangioendotheliomatosis with thrombocytopenia. (Maronn M, Catrine K, North P, Browning MB, Kerschner JE, Noel R, Drolet BA, Kelly M) Pediatr Blood Cancer 2009 Apr;52(4):531-4 PMID: 19058203
  • Renal cell carcinoma in a patient with cystinosis and inflammatory bowel disease: a case report. (Cameron C, Greenbaum L, Sato T, Trost B, Lundeen B, Kelly ME) Pediatr Nephrol 2008 Jul;23(7):1167-70 PMID: 18286306
  • Measuring fatigue for children with cancer: development and validation of the pediatric Functional Assessment of Chronic Illness Therapy-Fatigue (pedsFACIT-F). (Lai JS, Cella D, Kupst MJ, Holm S, Kelly ME, Bode RK, Goldman S) J Pediatr Hematol Oncol 2007 Jul;29(7):471-9 PMID: 17609625
  • Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias. (Rao A, Kelly M, Musselman M, Ramadas J, Wilson D, Grossman W, Shenoy S) Pediatr Blood Cancer 2008 Apr;50(4):822-5 PMID: 17570702
  • Successful umbilical cord blood stem cell transplantation in a patient with Rothmund-Thomson syndrome and combined immunodeficiency. (Broom MA, Wang LL, Otta SK, Knutsen AP, Siegfried E, Batanian JR, Kelly ME, Shah M) Clin Genet 2006 Apr;69(4):337-43 PMID: 16630167
  • Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation. (Blaeser F, Kelly M, Siegrist K, Storch GA, Buller RS, Whitlock J, Truong N, Chatila TA) Clin Immunol 2005 Dec;117(3):231-7 PMID: 16169277
  • Posttransplantation lymphoproliferative disorder in children: clinical, histopathologic, and imaging features. (Pickhardt PJ, Siegel MJ, Hayashi RJ, Kelly M) Radiology 2000 Oct;217(1):16-25 PMID: 11012419
  • High incidence of posttransplant lymphoproliferative disease in pediatric patients with cystic fibrosis. (Cohen AH, Sweet SC, Mendeloff E, Mallory GB Jr, Huddleston CB, Kraus M, Kelly M, Hayashi R, DeBaun MR) Am J Respir Crit Care Med 2000 Apr;161(4 Pt 1):1252-5 PMID: 10764320
  • Apolipoprotein E restricts interleukin-dependent T lymphocyte proliferation at the G1A/G1B boundary. (Mistry MJ, Clay MA, Kelly ME, Steiner MA, Harmony JA) Cell Immunol 1995 Jan;160(1):14-23 PMID: 7842480
  • Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity. (Kelly ME, Clay MA, Mistry MJ, Hsieh-Li HM, Harmony JA) Cell Immunol 1994 Dec;159(2):124-39 PMID: 7994749
  • alpha-Difluoromethylornithine induces differentiation of a human embryonal carcinoma cell line in vitro. (Uhl L, Kelly M, Schindler J) Biochem Biophys Res Commun 1986 Oct 15;140(1):66-73 PMID: 3096321
  • Alterations in polyamine metabolism during embryonal carcinoma cell differentiation in vitro. (Kelly M, McCann PP, Schindler J) Dev Biol 1985 Oct;111(2):510-4 PMID: 3930315
  • The response of several murine embryonal carcinoma cell lines to stimulation of differentiation by alpha-difluoromethylornithine. (Schindler J, Kelly M, McCann PP) J Cell Physiol 1985 Jan;122(1):1-6 PMID: 3917438
  • Inhibition of ornithine decarboxylase induces embryonal carcinoma cell differentiation. (Schindler J, Kelly M, McCann PP) Biochem Biophys Res Commun 1983 Jul 18;114(1):410-7 PMID: 6411082
  • Last update: 07/30/2015